Skip to content

Independent GLP-1 journalism

On The Jab

How to win a GLP-1 prior authorization appeal

Most denials are not clinical judgments. They are documentation failures, and documentation failures are the kind you can fix — if you know what the reviewer on the other end is actually reading.

NR

Dr. Nick Robertson

Founder & Editor

Published
Reading time
6 min read
Medically reviewed
Clinically reviewed

The denial letter is designed to end the conversation. It is vague, it arrives with a fax number from 1998, and it uses the phrase “not medically necessary” about a person the reviewer has never met.

A large share of these are overturned when challenged. Most people never challenge them.

Step zero: find out whether you can win at all

Before anything else, establish which of two situations you are in.

A denial means the drug is a covered benefit and you did not meet the criteria. This is appealable and frequently winnable.

An exclusion means your plan does not cover weight-loss drugs at all. No amount of documentation creates a benefit that does not exist. Appealing an exclusion wastes months.

Ask your plan directly, in writing: Is there a weight-management pharmacy benefit under this plan, and if so what are the coverage criteria? If your coverage runs through an employer, the benefits team knows this and the pharmacy help line often does not.

Half the appeals I have watched people file were doomed on day one, because they were arguing about criteria for a benefit their plan had never purchased.

The five documents you need

Reviewers are working from a checklist. Give them the checklist, completed.

  1. The written denial letter. Not the phone call. The letter states the specific criterion cited and the appeal deadline. Request it if it has not arrived.
  2. The plan’s coverage policy for the drug. Most publish these. It tells you the exact BMI thresholds, comorbidity list, and step-therapy requirements you are being measured against.
  3. Documented BMI history. Ideally showing the threshold has been met over time, not just at one visit.
  4. Comorbidity documentation. Hypertension, prediabetes or diabetes, dyslipidaemia, obstructive sleep apnea, fatty liver disease, osteoarthritis, cardiovascular disease. Each needs to be an actual coded diagnosis in the record, not a mention in a note.
  5. Evidence of prior attempts. Lifestyle intervention, prior medications tried and failed, dates and outcomes. This is the criterion people most often fail on paper while having met it in life.

The letter of medical necessity

This is written by your clinician, and its quality decides most appeals. A good one is short and answers the criterion. A bad one is a passionate paragraph about how much the patient needs help.

It should contain, plainly:

  • The diagnosis with its ICD code
  • BMI, with dates, and the comorbidities that qualify
  • What has been tried, when, and what happened
  • Why this specific drug, referencing the plan’s own criteria language
  • What is expected to happen without treatment

If the denial cited step therapy, the letter must say which step-therapy drug was tried, for how long, and why it was stopped. Anything else is a letter about a different question.

The escalation ladder

StageWhat it isTypical window
Peer-to-peerYour clinician speaks directly to the plan’s medical directorRequest immediately after denial
Internal appealFormal written appeal to the planCommonly up to 180 days from denial
Second internal appealWhere the plan offers onePer plan rules
External reviewIndependent third-party reviewer; the plan must comply with the outcomeCommonly within 4 months of final internal denial
Expedited reviewFor urgent clinical situationsDays, not months

External review is the step people do not know exists. The reviewer is not employed by your insurer and their decision binds the plan. If you have a documented case and the plan has been unreasonable, this is where that becomes visible.

Angles people miss

The indication you apply under is frequently the whole game. A documented cardiovascular history opens a route that a weight-loss request does not — see the SELECT data and the label change — and the thresholds themselves are set out in do you qualify.

A different indication. If you have established cardiovascular disease with overweight or obesity, or diagnosed moderate-to-severe sleep apnea, the approved indication may not be weight loss at all — which sidesteps a weight-loss exclusion entirely. This is not a trick; it is a different, legitimate prescription that requires the diagnosis to actually exist and be documented.

The formulary alternative. Sometimes the plan will cover a different agent than the one prescribed. Asking which GLP-1 is on formulary is faster than fighting for the one that is not.

The employer. In self-funded plans, the employer sets the benefit, and the insurer only administers it. Benefits teams have reversed exclusions after enough employees asked. Your HR department is a stakeholder, not a bystander.

The state insurance commissioner. For fully insured plans, a complaint costs nothing and occasionally produces a very fast reconsideration.

What to expect

It takes weeks. It involves being on hold. It requires you to be the project manager of your own case, because nobody else in the system is assigned to it.

That is an indictment of how American coverage works, not advice. But while it is the system, the people who get medication are disproportionately the people who filed the second appeal.

Keep a log: every call, the date, the name of the person, the reference number. It feels excessive until the fourth call, when it becomes the only reason you have a case.

The same discipline applies on the clinical side of the file. An appeal is far stronger when it can show a documented trajectory — dose, weight, blood pressure, side effects, all dated — than when it asserts in a sentence that treatment has helped. If you are already tracking that somewhere, export it and attach it. If you are not, Zenday will produce something you can hand over, and starting today still leaves you with a real record by the time the next renewal comes round.

Common questions

How do I appeal a denied GLP-1 prior authorization?
Request the written denial letter and the plan's coverage criteria, identify the exact criterion cited, gather documentation addressing that specific criterion, and file an internal appeal before the deadline. If that fails, request an external review by an independent third party, which most US plans are required to offer.
Why was my Wegovy prior authorization denied?
The most common reasons are a plan-level exclusion of weight-loss drugs, missing documentation of BMI or comorbidities, no record of prior lifestyle intervention, a step-therapy requirement that has not been met, or the wrong diagnosis code on the claim.
What is the difference between a plan exclusion and a denial?
A denial means you did not meet the criteria and can appeal. An exclusion means the benefit does not exist in your plan at all, and no appeal will create it. Establishing which one you are facing is the first thing to do, because it determines whether appealing is worth your time.
How long do I have to appeal an insurance denial?
Deadlines are set by the plan and by law, and are commonly 180 days from the denial for internal appeals, with a shorter window for external review afterwards. The exact dates are stated in your denial letter.

Sources

  1. 01

    Centers for Medicare & Medicaid Services. Internal claims and appeals and external review.

  2. 02

    US Department of Labor. Filing a claim for your health benefits — ERISA plans.

  3. 03

    Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389:2221-2232.

Editorial standards

Written by Dr. Nick Robertson, MD. Clinical content last checked August 6, 2026. On The Jab takes no money from pharmaceutical companies, telehealth platforms or compounders, and uses no affiliate links. Read our policy.

This article is journalism and general education, not medical advice. Talk to your own clinician before changing any treatment.

The Sunday Dispatch

Get the next one in your inbox.

One email a week from Dr. Robertson. Free, and it stays free.

Keep reading

Guide//6 min

Do you qualify for a GLP-1?

Clinical eligibility is a short, public, unambiguous rule. Whether anyone will pay for it is a completely separate question, and conflating the two is why so many people believe they were turned down for being too healthy.

Explainer//6 min

GLP-1s for teenagers

Wegovy has been licensed for twelve-year-olds since 2022 and the trial data is strong. The disagreement is not really about whether the drug works, which is why it has not resolved.

Deep Dive//5 min

The GLP-1 heart benefit

SELECT enrolled seventeen thousand people with heart disease and no diabetes, and found a twenty percent reduction in cardiovascular events. The label change that followed did more for access than any argument about obesity ever has.

The book · 14 chapters

The GLP-1 Handbook

Everything I tell my own patients before their first injection. 214 pages of what actually matters in the first year — dosing, side effects, food, muscle, cost, and the part nobody prepares you for: maintenance.

$4Less than your morning coffee.
Read the first chapter

Priced at four dollars because it should be affordable to everyone taking these drugs — not because it's worth four dollars. No upsell, no course, no supplement line.